Trial 1: Clinical Trial with Advair HFA 45 mcg/21 mcg A placebo-controlled, 12-week, US trial compared Advair HFA 45 mcg/21 mcg with fluticasone propionate CFC inhalation aerosol 44 mcg or ...
One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, ...
Additionally, patients in the Flovent HFA arm achieved statistically significantly improved lung function, fewer asthma symptoms, and less use of Ventolin Inhalation Aerosol compared with those in ...
BACKGROUND: Efficacy of inhaled fluticasone propionate (FP) for management of recurrent airway obstruction (RAO) has only been evaluated after several weeks' treatment. OBJECTIVES: To compare ...
The researchers found that dry powder triple inhaler therapy of fluticasone-umeclidinium-vilanterol resulted in fewer COPD exacerbations compared to metered dose triple inhaler therapy of ...
a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback